StockData
BeOne Medicines Ltd. logo

BeOne Medicines Ltd. (ONC) operating KPIs

ONCNasdaqPharmaceutical PreparationsFiscal year ends December 31Also trades as BEIGF
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 5, 2026Score 12/302313% above fair value
$370.33−1.23 (-0.33%)

Close on Oct 30, 2026Market cap $42.11BP/E 66.2Yield –

BeOne Medicines total operating expenses ($M) ($M)

Form 10-Q / 10-K (DB)

Latest, Q2 2026
1,206
Period ended Jun 30, 2026
Change on a year earlier
+13.4%
1,063 in Q2 2025
History
45 quarters
Since Q2 2015
Sources
36
Documents cited below

Quarterly history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedTotal operating expenses ($M) ($M)Year on yearSource
Q2 2026Jun 30, 20261,206+13.4%Form 10-Q (filed 2026-08-05) ↗
Q1 2026Mar 31, 20261,096+16.5%Form 10-Q (filed 2026-05-06) ↗
Q4 2025Dec 31, 20251,171+11.8%Form 10-K (filed 2026-02-26) ↗
Q3 2025Sep 30, 20251,053+10.6%Form 10-Q (filed 2025-11-06) ↗
Q2 2025Jun 30, 20251,063+18.3%Form 10-Q (filed 2025-08-06) ↗
Q1 2025Mar 31, 2025941+6.0%Form 10-Q (filed 2025-05-07) ↗
Q4 2024Dec 31, 20241,047+14.7%Form 10-K (filed 2025-02-27) ↗
Q3 2024Sep 30, 2024951+16.2%Form 10-Q (filed 2024-11-12) ↗
Q2 2024Jun 30, 2024898+9.8%Form 10-Q (filed 2024-08-07) ↗
Q1 2024Mar 31, 2024888+20.5%Form 10-Q (filed 2024-05-08) ↗
Q4 2023Dec 31, 2023912+62.3%Form 10-Q (filed 2024-11-12) ↗
Q3 2023Sep 30, 2023819-0.8%Form 10-Q (filed 2024-11-12) ↗
Q2 2023Jun 30, 2023818+4.7%Form 10-Q (filed 2024-08-07) ↗
Q1 2023Mar 31, 2023737-1.7%Form 10-Q (filed 2024-05-08) ↗
Q4 2022Dec 31, 2022562-9.4%Form 10-K (filed 2024-02-26) ↗
Q3 2022Sep 30, 2022826+23.5%Form 10-Q (filed 2022-11-09) ↗

Cite this data

StockData. (2026). BeOne Medicines Total operating expenses ($M) ($M), quarterly Q2 2015–Q2 2026 [Data set]. Compiled from BeOne Medicines SEC filings and investor materials. https://stockdatahq.com/stocks/onc/kpis/fs_tot_opex

See every metric in the BeOne Medicines KPI table. Data updated Oct 29, 2026.